Curated Business Corporate News

NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.

EOS Divests EM Solutions Segment, Focuses on Core Operations and Growth

December 29, 2024Stonegate Capital Partners updates coverage on Electro Optics Systems Holdings Ltd (ASX: EOS) as the company divests its EM Solutions segment for $144.0M, focusing on core operations and growth. Learn about EOS's diversification, new contracts, and turnaround program, signaling positive performance ahead.


Burcon Nutrascience Corporation Makes Strides in Canola Protein Commercialization

December 29, 2024Stonegate Capital Partners updates coverage on Burcon Nutrascience Corporation as the company achieves a significant milestone in canola protein commercialization. With a robust sales pipeline and multi-billion-dollar addressable market, Burcon is well-positioned for growth in the plant-based protein industry.


Stonegate Capital Partners Updates Coverage on Hooker Furniture Corporation (NASDAQ: HOFT)

December 29, 2024Stonegate Capital Partners updates coverage on Hooker Furniture Corporation (NASDAQ: HOFT), revealing financial performance, growth strategies, and market outlook. Learn about HOFT's commitment to dividends, inventory reduction, and positive valuation outlook. Stay informed on key developments impacting HOFT's stock performance and future prospects.


Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. for Q3 2024

December 29, 2024Stonegate Capital Partners provides an update on Bio-Path Holdings, Inc. for Q3 2024, emphasizing the company's innovative drug candidates and breakthrough technology in cancer treatment. With a strong IP position and strategic relationships, Bio-Path is poised for success and potential growth in the biopharmaceutical industry.


Clene Receives FDA Guidance for Accelerated Approval Pathway for CNM-Au8 in ALS

December 27, 2024Clene (NASDAQ: CLNN) and its subsidiary, Clene Nanomedicine Inc., received FDA guidance for potential accelerated approval of their lead drug candidate CNM-Au8 in ALS. The guidance followed a Type C meeting where Clene presented additional clinical trial data and analyses. Clene plans to submit an NDA under the accelerated approval pathway in mid-2025.


Cloud 9 Tubs LLC Receives 2024 Angi Super Service Award

December 27, 2024Cloud 9 Tubs LLC has been honored with the 2024 Angi Super Service Award for their exceptional bathroom transformation services, demonstrating a commitment to customer satisfaction and quality craftsmanship.


Harper Surveying Sets New Standards with Precision Surveying Equipment

December 26, 2024Harper Surveying sets new standards in precision surveying equipment, offering high-quality, innovative solutions to meet the evolving demands of the industry. With a legacy of innovation and customer satisfaction, Harper Surveying's expanded lineup of equipment caters to professionals seeking advanced technology, durability, and affordability.


EdenMountain Launches Groundbreaking Digital Marketplace for ENORs

December 25, 2024EdenMountain launches the world’s first digital marketplace for Enterprise Non-Operating Rights (ENORs), marking a transformative moment in how businesses and investors approach intellectual property. With over 290 ENORs listed across various industries, the platform enables businesses to monetize unused intellectual property in a debt-free, non-dilutive manner, offering investors access to a unique asset class with high-growth potential.